Background and Purpose—Methods of performing and reporting randomized clinical trials
(RCTs) are available, but weaknesses still occur. For observational studies, methodology is …

Subarachnoid hemorrhage (SAH) is a common and fre-quently devastating condition,
accounting for 5% of all strokes and affecting as many as 30 000 Americans each year. 1, 2 …

Purpose—The aim of this guideline is to present current and comprehensive
recommendations for the diagnosis and treatment of aneurysmal subarachnoid hemorrhage …

Outcome of patients with aneurysmal subarachnoid hemorrhage (SAH) has improved over
the last decades. Yet, case fatality remains nearly 40% and survivors often have permanent …

Researchers and other stakeholders continue to express concern about the failure of
randomized clinical trials (RCT) in subarachnoid hemorrhage (SAH) to show efficacy of new …

Background and Purpose—The rationale behind early aneurysm surgery in patients with
subarachnoid hemorrhage (SAH) is the prevention of rebleeding as early as possible after …

The outcome of patients with aneurysmal subarachnoid hemorrhage (SAH) has improved
slowly over the past 25 years. This improvement may be due to early aneurysm repair by …

Object. Based on the concept that unfavorable clinical outcome after aneurysmal
subarachnoid hemorrhage (SAH), to a large extent, is a consequence of all ischemic insults …

Background The neurointensive care management of patients with aneurysmal
subarachnoid hemorrhage (aSAH) is one of the most critical components contributing to …

Introduction In studies on aneurysmal subarachnoid hemorrhage (SAH), substantial
variability exists in the use and timing of outcomes and endpoints, which complicates …